Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GNAI3 | P08754 | 5/20 | 0.33 |
| ▸ | GNAO1 | P09471 | 5/20 | 0.33 |
| ▸ | GNAI1 | P63096 | 5/20 | 0.33 |
| ▸ | CARM1 | Q86X55 | 2/20 | 0.32 |
| ▸ | PRMT6 | Q96LA8 | 2/20 | 0.32 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.32 |
| ▸ | PRMT8 | Q9NR22 | 1/20 | 0.32 |
| ▸ | CPN1 | P15169 | 1/20 | 0.32 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.32 |
| ▸ | DRD2 | P14416 | 2/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | HTR2A | P28223 | 1/20 | 0.30 |
| ▸ | HTR2C | P28335 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25075207 | 0.86 | GNAI3 (0.38) | GNAI3GNAO1GNAI1CARM1PRMT6 | |
| SCHEMBL4762635 | 0.82 | DRD2 (0.46) | GNAI3GNAO1GNAI1DRD2 | |
| SCHEMBL26494066 | 0.82 | GNAO1 (0.44) | GNAI3GNAO1GNAI1 | |
| SCHEMBL24257195 | 0.82 | OPRM1 (0.30) | CPN1CPB2 | |
| SCHEMBL16980461 | 0.79 | ALOX15 (0.35) | GNAI3GNAO1GNAI1HTR2A | |
| SCHEMBL10052289 | 0.78 | ARG1 (0.38) | GNAI3GNAO1GNAI1CARM1PRMT6 | |
| SCHEMBL1615678 | 0.78 | GNAO1 (0.50) | GNAI3GNAO1GNAI1 | |
| SCHEMBL12384241 | 0.78 | GNAI3 (0.33) | GNAI3GNAO1GNAI1CARM1PRMT6 | |
| SCHEMBL2603219 | 0.78 | SLC18A3 (0.43) | GNAI3GNAO1GNAI1CARM1PRMT6 | |
| SCHEMBL4371445 | 0.78 | ALOX15 (0.50) | GNAI3GNAO1GNAI1CARM1PRMT6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110201593-A1 | TRICYCLIC HETEROCYCLIC COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF | GENENTECH, INC. (US) | 2011-08-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110201593-A1 | TRICYCLIC HETEROCYCLIC COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF | CCNY, CCNA1, CCNA2 | GNAI3 3226/4885GNAO1 2674/4885GNAI1 2658/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.